About

Zoltan obtained his PhD in Biophyics from Harvard University in the laboratory of Dr. Timothy Mitchison where he studied the mechanism of small molecule inhibitors of kinesin motor proteins to investigate the mechanochemistry and also develop a novel class of anti-cancer agents. He received postdoctoral training in the laboratory of Dr. Anthony Hyman at the MPI-CBG in Dresden, Germany to investigate the regulation of cytoskeletal motor proteins by systematic transgenesis, fluorescent imaging and affinity-purification mass spectrometry in human cells. He returned to the laboratory of Dr. Mitchison to study signaling in the STING pathway and identified novel activators as potential anti-cancer and anti-viral agents. Zoltan is now a senior research scientist in the Laboratory of Systems Pharmacology at Harvard Medical School. His research combines highly multiplexed imaging, high spatial-resolution mRNA transcript profiling of clinical biopsies and surgical resections to study immune responses to cancer and infectious disease in a real world context.